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The present study was designed to investigate the possible cytotoxicity and biocompatibility of scaf-
folds based on previously characterized polymeric materials including poly--caprolactone (PCL)
or polydiisopropyl fumarate (blended or on their own), with or without hydroxyapatite (HAP). Water
contact angle was also evaluated to determine the hydrophylicity of each scaffold. Degradation of
different scaffolds was evaluated after a 10-week incubation in Dulbecco’s modiﬁed eagle medium
(DMEM) supplemented with 5% (v/v) fetal bovine serum (FBS). Bone Marrow Stromal Cells (MSC)
were grown on different scaffolds in an osteogenic medium, after which alkaline phosphatase activity
(ALP) was evaluated. ALP activity increased when MSC were grown on PCL+HAP or Blend+HAP,
as compared to PCL or Blend without HAP. The effect of different scaffolds on the proliferation of the
macrophage cell line RAW 264.7, production of nitric oxide (NO) and secretion of pro-inﬂammatory
cytokines was examined. After 72 h, macrophages proliferated equally well on all scaffolds, main-
taining a rounded morphology. None of the investigated scaffolds induced production of NO or
cytokine release into the culture media, suggesting an absence of cytotoxicity. Therefore, these
polymer- and HAP-based scaffolds could potentially be used as bone substitute materials.
Keywords: Cytotoxicity, Bone Tissue Engineering, Bone Marrow Stromal Cells, RAW 264.7
Macrophages, Poly-Epsilon-Caprolactone, Polydiisopropyl Fumarate.
1. INTRODUCTION
Medical procedures necessary for the treatment of sig-
niﬁcant bone tissue damage generate important costs to
the health care system.1–5 Traditionally, in order to repair
extensive lesions, patients have been submitted to either
bone grafts (autografts, allografts and xenografts) or metal-
lic grafts (prosthesis, osteosynthesis plates). Infectious dis-
ease transmission, lack of integration, fatigue and wear
of metals, as well as the low availability of bone donors
and graft rejection, represent some of the complications.
Bone tissue engineering (BTE) uses concepts and prin-
ciples from different ﬁelds (medicine, engineering, bio-
chemistry) to restore or improve the damaged tissue.6
Three-dimensional scaffolds have been developed with
various materials to support different types of cells and
growth factors in its interior. In theory, once the scaffold
is implanted in the patient, it will guide the regeneration
∗Author to whom correspondence should be addressed.
of bone tissue.7 Currently, a number of different materials
are being developed and evaluated for their possible
application in the area of bone regeneration.7–11 However
all these materials must meet several important require-
ments for their application in this area, such as: lack
of immunogenicity, a timely biodegradation rate which
allows for adequate growth of the new tissue, non-toxic
degradation products, and appropriate mechanical proper-
ties in order to provide structural stability to a bone defect
site while resilient to mechanical stress.12
We have previously reported the development,
characterization and biocompatibility of a new com-
patibilized polymeric material based on two polymers,
poly--caprolactone (PCL) and polydiisopropyl fumarate
(PDIPF).13 Using these homopolymers we have developed
a blend (PCL-PDIPF) compatibilized by ultrasound, which
shows better biocompatibility and mechanical properties
compared to that of the homopolymers. We have also
shown that the physicochemical and osteogenic properties
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improve with the addition of 1% w/w of hydroxyapatite
(HAP) obtained and characterized in our laboratory from
bovine bone.14 An important aspect in the development of
a bone scaffold is the possible inﬂammatory response that
the material could induce in an in vivo application. A ﬁrst
approach to this aspect may be reached by investigating
the in vitro response of macrophages in culture, such as
murine RAW 264.7 cells. This cell line is highly sensitive
to cytotoxic agents and responds by sharply increasing
pro-inﬂammatory cytokines such as interleukin-1 (IL-1)
and tumor necrosis factor-alpha (TNF-) as well as the
production of nitric oxide (NO). Due to these features,
macrophages in culture constitute an excellent model
for cytotoxicity studies with various substances in bio-
logical systems.15–22 In particular, studies that evaluate
the possible cellular toxicity of biomaterials are of great
interest for their possible biomedical applications. The
main aim of this study was to evaluate the possible cyto-
toxicity and biocompatibility of scaffolds prepared with
PCL, PCL+HAP (1% w/w), PCL+PDIPF (blend), and
blend+HAP (1% w/w), using RAW 264.7 macrophages
(cytotoxicity) or bone marrow stromal cells (MSC, for
biocompatibility studies). In addition, the hydrophobicity
and degradability of the materials were evaluated and
correlated with cellular studies.
2. MATERIALS AND METHODS
2.1. Preparation of Composite Scaffolds
PCL was purchased from Aldrich and has a weight-
average molecular weight (MW ) and polydispersity index
(PI) of 65000 g ·mol−1 and 1.4, respectively, as indi-
cated by the manufacturer. PDIPF was synthesized by
microwave-assisted radical polymerization, using ben-
zoyl peroxide as the initiator, as we have previously
described.23 PDIPF weight-average molecular weight and
polydispersity index were 131000 g · mol−1 and 2.0,
respectively, as determined by size exclusion chromatog-
raphy (SEC). Compatibilized blends of PCL and PDIPF
(75:25 wt%; Blend) were obtained by ultrasound using
Bandelin HD60 equipment at 20 C, following the previ-
ously described methodology.13 This particular composi-
tion was selected based on our preliminary studies. The
Mw and molecular weight distribution of the polymers
were determined by size exclusion chromatography, using
an LKB-2249 instrument at 25 C. A series of -Styragel
columns, pore sizes 105, 104, 500 and 100 Å, were used
with chloroform as an eluent. The polymer concentration
was 4–5 mg/ml and the ﬂow rate was 0.5 ml/min. The
polymer was detected at 5.75 m with a Miran 1A infrared
spectrophotometer detector and calibration was performed
using poly(methyl methacrylate) as a standard. Hydrox-
yapatite (HAP) was obtained from adult bovine femur as
previously described.14 Composites of 1 wt% HAP and
PCL or Blend were obtained by dissolution in chloroform
and casting in a glass Petri dish. The solvent was allowed
to evaporate at room temperature and then the resulting
ﬁlms were dried under vacuum until constant weight. The
ﬁlms were sterilized by UV exposure for 2 h.13114
2.2. Characterization of Scaffolds
2.2.1. Water Contact Angle
Water contact angle measurements of the ﬁlms were car-
ried out using a ramé-hart Model 500 goniometer (ramé-
hart instrument co., USA) in the contact angle mode.
Images were analyzed with DROPimage Advanced v2.2
software. All the tests were performed on the air-facing
surfaces of the samples. Six measurements on different
points were performed to calculate the mean static contact
angle.
2.2.2. Degradation of Films
Film degradation was studied after incubation in DMEM
supplemented with 10% v/v foetal bovine serum (FBS),
in a humidiﬁed atmosphere of 95% air and 5% CO2 at
37 C. Film samples were cut, weighed (W0) and placed in
a 24-well plate. After UV sterilization, Dulbecco’s modi-
ﬁed eagle medium (DMEM) was added to each well. The
culture medium was replaced once a week: during this
weekly procedure, each ﬁlm sample was washed, dried
and weighed (Wt). Film degradation was evaluated as the
weight loss percentage (%W), calculated according to the
following Eq. (1)
%W = 4Wo−Wt5×100/Wo (1)
2.3. Biocompatibility Studies with MSC
Bone marrow stromal cells (MSC) were obtained from
rats as described previous. (They were characterized by
their ability to differentiate to various phenotype, such as
osteoblasts, adipocytes, chondrocytes).24 Brieﬂy, animals
were sacriﬁced under anesthesia by rapid neck disloca-
tion. MSC were collected by ﬂushing the dissected femoral
and tibial diaphysis medullary canal with DMEM (Invit-
rogen, Buenos Aires, Argentina) under sterile conditions.
The resulting suspension was seeded in a 25 cm2 tissue
culture ﬂask. Cells were grown in DMEM supplemented
with 5% (v/v) FBS and antibiotics (100 U/ml penicillin
and 100 g/ml streptomycin) in a humidiﬁed atmosphere of
95% air and 5% CO2. For the experiments, polymeric ﬁlms
were cut to size and placed in a 24-well plate. MSC were
plated on each ﬁlm slice at a density of 5×104 cells/well,
and cultured in 10% FBS–DMEM at 37 C. After cells
reached conﬂuence, they were induced to differentiate
into osteoblasts using an osteogenic medium (DMEM–
10% FBS containing 25 mg/mL ascorbic acid and 5 mM
sodium -glycerol-phosphate), which was changed twice
a week. Osteoblastic differentiation was evaluated by mea-
suring alkaline phosphatase activity (ALP). After 15 days
of osteogenic differentiation, cell monolayers were washed
with phosphate-buffered saline (PBS) and the total cell
2 J. Biomater. Tissue Eng. 4, 1–8, 2014
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extract was obtained with 200 uL 0.1% Triton-X100.
A 100 uL aliquot of the extract was used to evaluate ALP
by hydrolysis of p-nitrophenylphosphate (p-NPP) into p-
nitrophenol (p-NP) at 37 C for 1 hour. The absorbance
of p-NP was recorded at 405 nm25. Aliquots of each cell
extract were used for protein determination by Bradford’s
technique.26
Alternatively, the viability of MSC grown on scaf-
folds was estimated using a colorimetric tetrazolium assay.
This assay measures the reduction of the tetrazolium salt
3-(4,5-dimrthylthiazol-2-yl)-2,5-diphenyl tetrazolium bro-
mide (MTT) to formazan by intact mitochondria in liv-
ing cells. Thus, absorbance change is directly proportional
to the number of viable cells.27 For this assay, 3× 104
MSC were plated in a 48-multiwell plate (with a poly-
mer ﬁlm placed in each well) and cultured for 24 hours in
10% FBS–DMEM at 37 C. The medium was removed,
cells were washed with PBS and fresh medium containing
the MTT reagent (Sigma, USA) at a ﬁnal concentration
of 1 mg/mL was added. After a 3-hour incubation each
ﬁlm was removed, placed in a new 48-multiwell plate and
washed again with PBS. Color was developed by addition
of 200 L dimethylsulfoxide (DMSO) (Merck, Argentina)
and mixing in a plate shaker for 20 minutes, after which
absorbance was measured at 540 nm.27
2.4. Cytotoxicity Studies with RAW
264.7 Macrophages
Murine macrophage RAW 264.7 cells were grown in
DMEM supplemented with 5% (v/v) FBS and antibiotics
(100 U/ml penicillin and 100 g/ml streptomycin) in a
humidiﬁed atmosphere of 95% air and 5% CO2. For the
experiments, polymeric ﬁlms were cut to size, inserted in
a 24-well plate and macrophages plated on them.
A mitogenic bioassay was carried out as described by
Okajima et al.28 with some modiﬁcations. Brieﬂy, RAW
264.7 cells grown on the ﬁlms were washed with PBS and
ﬁxed with 5% glutaraldehyde/PBS for 10 min. The cells
were then stained with 0.5% crystal violet (25% methanol)
for 10 min. Excess dye was discarded and the plate was
washed with water and dried. The dye taken up by the cells
was extracted using 0.5 mL/well 0.1 M glycine/HCl buffer,
pH 3.0/30% methanol, transferred to test tubes and the
absorbance was read at 540 nm. The correlation between
cell number and absorbance at 540 nm has been pre-
viously established.29130 Alternatively, cells were stained
with hematoxylin-eosin (H-E) after 24 hours of culture for
observation with an optical microscope.
Nitric oxide (NO) production was assessed using Griess’
reaction29131 (using sulfanilic acid as the diazotizing agent
and N -1-napthylethylene diamine as the coupling agent).
The stable end-product of NO and nitrite released into
the culture medium by RAW 264.7 cells was measured
after 24, 48 and 72 hours of culture. Brieﬂy, 400 l sam-
ples of conditioned media or nitrite standards 0–100 nM
were mixed with 400 l of Griess’ reagent (1% sulfanil-
amide and 0.1% naphthylethylene-diamine in 5% phospho-
ric acid) and absorbance was measured at 530 nm against
a blank prepared with non-conditioned medium.
The pro-inﬂammatory cytokines tumor necrosis factor-
alpha (TNF-) and interleukin-1 (IL-1) released into the
culture medium by RAW 264.7 cells were evaluated at 24,
48 and 72 hours by ELISA kits (Mouse IL-1LISA Set,
BD Biosciences OptEIA™ and TNF- kits Mouse ELISA
Set, BD Biosciences OptEIA™) following the manufactur-
ers instructions, as we have previously described.32
For NO and pro-inﬂammatory cytokine production,
RAW 264.7 cells were also plated on standard culture
tissue dishes with or without lipopolysaccharide (LPS,
0.1 g/ml) as positive and negative controls, respectively.
2.5. Statistical Analysis
Student’s t-test was used for comparisons between con-
trol and experimental groups. All results are expressed as
mean±S.E.M. and represent at least three different exper-
iments performed in triplicate.
3. RESULTS AND DISCUSSION
A large number of materials are currently being studied
for their application in bone tissue engineering. However,
there have been comparatively few studies on the possi-
ble cytotoxic effects of these materials on cultured cells,
a relevant feature for biomedical applications. We have
previously developed a new composite biomaterial based
on a compatibilized PCL-PDIPF blend including 1% wt
HAP, and thoroughly studied its physicochemical, mechan-
ical and biocompatibility properties using UMR106 rat
osteosarcoma cells and MC3T3E1 mouse calvaria-derived
cells.13114 We have also shown that both PCL and PDIPF
can be degraded by macrophages. Moreover, the studied
polyfumarates, although possessing a C–C main chain (see
Scheme 1), can be degraded under in vitro cellular condi-
tions by a phagocytic process.8 Cell behavior is not only
dependent on the chemical nature of a scaffold but also on
its topographical features,33134 hydrophilicity34–38 and the
initial cell-surface interaction.37–39 Many research groups
have focused their studies on the interactions between
cells and matrices in order to elucidate why membranes
with hydrophobic groups can facilitate cell attachment to
Scheme 1. Chemical structure of the polydiisopropyl fumarate and
poly--caprolactone used for scaffold preparation.
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Fig. 1. Water contact angle (WCA) of PCL, PCL+HAP, Blend and
Blend+HAP. PCL was more hydrophilic than the Blend, and the incor-
poration of HAP to the polymers increased their hydrophylicity. &: p <
00001 PCL versus PCL+HAP and Blend–versus Blend+HAP; @: p <
00001 Blend versus PCL.
scaffolds,40–44 and have concluded that it is due to initial
interactions between cells and scaffolds that are dependent
on weak bonds such as dipole–dipole. Although it is still
not understood how the hydrophobicity or hydrophilicity
of materials can regulate cellular activity and tissue regen-
eration, this is an important parameter to consider when
designing a scaffold. Thus, polymer-cell interactions can
be related to the wetting properties of the ﬁlm, thus inﬂu-
encing cellular behavior.45 In order to investigate these
aspects, the water contact angle (WCA) of the membranes
was evaluated in the present study. Figure 1 shows the
WCA of PCL and compatibilized blend polymer mem-
branes with and without the addition of HAP. The Blend
exhibited a signiﬁcantly higher WCA (75) than the PCL
membrane (70). We have previously reported the WCA
of a pure PDIPF ﬁlm (93),8 thus our present observations
for the blend are expected based on its chemical compo-
sition and are consistent with the chemical structure of
the polymers. PDIPF is a polymer comprising a carbon–
carbon chain that supports pendent isopropyl ester groups,
a structural feature that confers greater hydrophobicity
than the polyester PCL. On the other hand, the incorpo-
ration of HAP to both PCL and Blend scaffolds signif-
icantly reduced the WCA (66 and 70.5, respectively).
These observations are in agreement with previous reports
in which HAP was included in different scaffolds.34146
In our present study, the order of hydrophobicity of our
membranes was of PCL-HAP < PCL < Blend-HAP <
Blend. These differences could not be important from the
point of view of cell growth. We have previously reported
a change in the surface rough of membranes with or with-
out HAP.14 This property could in fact be expected to
modulate the adhesion, proliferation and differentiation of
cells.
Fig. 2. Degradation of PCL, PCL+HAP, Blend and Blend+HAP in
DMEM+ 10% FBS. PCL was degraded faster than the Blend after 35
days. Incorporation of HAP did not modify the degradation rate of poly-
mers. #: p < 0005; X: p < 0001; @: p < 00001.
(A)
(B)
Fig. 3. Biocompatibility studies. (A) Osteogenic differentiation of rat
MSC was evaluated by ALP activity. %: p < 0001 versus PCL. $: p <
0005 versus Blend; #: p < 0005 PCL versus Blend. (B) Viability of MSC
cultured on ﬁlms (shown as % of PCL). #: p < 0005 PCL versus Blend.
$: p < 0005 versus polymers without HAP.
4 J. Biomater. Tissue Eng. 4, 1–8, 2014
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Fig. 4. Proliferation of RAW 264.7 macrophages. RAW 264.7 cultured
for 24 hours on PCL, PCL+HAP, Blend or Blend+HAP (shown as %
of PCL). Macrophages proliferated equally on all the polymers for the
periods of time evaluated.
Another aspect that must be considered is that materials
must possess an adequate degradation rate, to ensure that
the scaffold does not collapse in the time-span needed for
cells to regenerate tissue.9147–49 We evaluated the degra-
dation rate of the different ﬁlms incubated in DMEM/5%
FBS for 10 weeks (Fig. 2). Although initially (0–20 days),
no signiﬁcant degradation of the scaffolds was observed,
after 5 weeks both PCL and PCL+HAP scaffolds showed
a faster degradation (almost twice) than either Blend or
Blend+HAP scaffolds. These differences could be due to
the chemical nature of the polymers. The blend includes
PFIP, a polymer with a C C catenarian structure that is
more difﬁcult to degrade than PCL. The latter is more sus-
ceptible to hydrolytic degradation due to its ester bonds
[–C–O–(C O)–].50 Interestingly, the introduction of HAP
into the scaffold did not modify the degradation rate.
Many authors have studied the degradation of polymeric
materials under different conditions. For example, Huang
et al.51 studied the degradation of a PLA–PCL–PLA tri-
block polymer in phosphate buffer solution (PBS). Other
authors have used different enzyme solutions such as
lipase52 or proteinase,53 as well as in the presence of
microorganisms54 to determine the degradation kinetics of
materials. We used DMEM+FBS because we believe this
medium is more representative of physiological conditions
than with lipase or PBS. Our results are in agreement
with those of other researchers51154 that have shown a
slow hydrolytic degradation for PCL when compared with
other polyesters, but faster than that of polymers such as
PDIPF (which is included in our compatibilized blend).
We believe that the relatively slow degradation rate of PCL
or the PCL–PDIPF blend, would allow MSC to proliferate,
differentiate into osteogenic cells and thus regenerate the
damaged bone tissue.
We next evaluated whether the PCL or PCL-PDIPF
blend polymers with and without hydroxyapatite (HAP),
were cytotoxic for RAW 264.7 macrophages and/or bio-
compatible with MSC.
The ability of MSC to differentiate into osteoblasts and
express ALP when grown on different ﬁlms was investi-
gated after 15 days of osteogenic induction (Fig. 3(A)).
ALP expression was higher in cells growing on the Blend
than in cells cultured on PCL ﬁlms (#: p < 0005). The
addition of HAP to ﬁlms increased cellular expression of
ALP both for PCL (%: p < 0001) and for the Blend ($:
p< 0005). We have previously demonstrated that the incor-
poration of HAP to PCL and Blend, increased their bio-
compatibility with cloned osteoblastic cell lines.14 In the
present study, we have used MSC to evaluate biocompat-
ibility, since these cells represent a better model for bone
tissue regeneration. The viability of MSC grown on differ-
ent ﬁlms was evaluated with the MTT assay. Figure 3(B)
shows that the viability of cells was higher for the Blend
than for PCL (#: p < 0005), and that the addition of HAP
to polymers further increased cellular viability. We also
measured WCA to evaluate the hydrophobicity of the dif-
ferent scaffolds, and found that the addition of HAP to the
polymers decreased their WCA. This effect was associated
with an increase in the viability of MSC. Another interest-
ing approach could be to study to differentiation without
using an osteogenic medium, but get it as a consequence
Fig. 5. Morphology of RAW 264.7 macrophages. Cells stained with H–
E after 24 hours of culture on PCL (A), PCL+HAP (B), Blend (C),
Blend+HAP (D), standard plastic tissue culture dish (E) or plastic tis-
sue culture dish in the presence of LPS (F). In the positive control (F),
macrophages appear activated with multiple cellular extensions and a vac-
uolated cytoplasm; these characteristics are absent in macrophages grown
on control and polymeric scaffolds. Magniﬁcation X1000.
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(A)
(B)
(C)
Fig. 6. cytotoxicity studies. Levels of NO (expressed as nmol of
Nitrite/well) (A), IL-1 (B) and TNF- (C) produced by RAW 264.7
macrophages cultured on standard plastic tissue culture dishes (control),
control+LPS, PCL, PCL+HAP, Blend or Blend+HAP. No signiﬁcant
differences were observed in the release of NO or secretion of cytokines
by macrophages grown either on control culture dishes or on the differ-
ent polymeric scaffolds. LPS induced a signiﬁcant increase in all pro-
inﬂammatory markers. ±: p < 00001.
of cues coming from the substrate. New experiments are
in progress to test this hypothesis.
Previously, our group32 and other researchers16118 have
shown that macrophages are a very sensitive culture model
to evaluate possible in vitro inﬂammatory responses to
a material with potential applications in tissue engineer-
ing. In the present study, we investigated the capacity
of RAW 264.7 macrophages to proliferate on different
scaffolds. Figure 4 shows that after 24–72 hours, cells pro-
liferate equally well on all scaffolds. Thus, the hydrophilic-
ity (and/or chemical nature) of our membranes apparently
does not affect the proliferation of macrophages, contrary
to what has been reported for other cell lines.8113114132155
In addition, we analyzed cell morphology after H–E
staining. Cells growing on different scaffolds or on stan-
dard plastic tissue culture dishes showed a rounded mor-
phology with few cytoplasmic extensions (Fig. 5(A)).
On the contrary, when cells on plastic dishes were
exposed to LPS, as a positive control of cytotoxicity, they
showed an expanded and vacuolated cytoplasm with sev-
eral extensions, suggesting activation of the macrophages
(Fig. 5(B)).
As has been pointed out above, a very important require-
ment of biomaterials is that the scaffolds must not be
toxic because they have been designed for incorporation
into a living organism. Therefore, the materials devel-
oped in our laboratory were evaluated to determine their
potential cytotoxicity, assessing the release of NO and the
pro-inﬂammatory cytokines TNF- and IL-1,15–17119–22 by
macrophages cultured on the different materials for 24–
72 hours. Figure 6(A) shows that NO release from cells
grown on all evaluated polymers was similar to control
(standard plastic tissue culture dish). When 0.1 g ·ml−1
LPS was added to the culture medium as a positive control
of cytotoxicity, a statistically signiﬁcant (±: p < 00001)
increase in NO release to the culture media was detected.
In addition, Figures 6(B) and (C) shows that there was
no signiﬁcant difference in the levels of TNF- and IL-1
secreted into the culture medium between cells grown on
the different polymeric scaffolds, or standard plastic tis-
sue culture dishes. Again, in the presence of LPS cells
responded by increasing the production of both cytokines
after 24 to 72 h of culture. Thus, the secretion levels
of NO, TNF- and IL-1 to the culture media correlate
with cell morphology (Figs. 5(A)–(D)), suggesting that the
scaffolds do not induce cytotoxicity during the periods of
time tested. On the other hand, macrophages responded
as expected to an established toxic agent such as LPS
by becoming morphologically (Fig. 5(F)) and functionally
activated, increasing NO and cytokine release into the cul-
ture media.
4. CONCLUSION
Our in vitro results show that RAW 264.7 macrophages
cultured on ﬁlms of PCL and PCL-PDIPF Blend, with or
without HAP, do not increase the secretion of NO, IL-1 or
TNF- during the evaluated culture periods. In addition,
the differences in hydrophobicity (and/or chemical nature)
between the different scaffolds do not induce changes in
6 J. Biomater. Tissue Eng. 4, 1–8, 2014
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the proliferation of RAW 264.7 macrophages. However,
changes in hydrophobicity (and/or chemical nature) can
produce changes in the viability and biocompatibility of
MSC. In addition, the degradation rate of PCL and PCL-
PDIPF Blend, with or without HAP was shown to be
relatively slow in comparison with another polyesters scaf-
folds. Thus, these polymer-based scaffolds could be poten-
tially useful for clinical applications such as materials for
bone tissue engineering. In order to investigate this impor-
tant issue, we are currently undertaking in vivo studies
using these new materials.
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